Top Markets
#1 Official Trump Official Trump +41.49%
#2 Melania Meme Melania Meme +20.81%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +20.58%
#4 Nockchain Nockchain +20.47%
#5 Mubarak Mubarak +19.32%
#6 EXOD EXOD +18.93%
#7 Pump.fun Pump.fun +16.04%
#8 Unit Pump Unit Pump +15.83%
#9 MowCat MowCat +14.02%
#10 Wrapped POL Wrapped POL +13.94%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
FUREN Group Pharmaceutical Co., Ltd. FUREN Group Pharmaceutical Co., Ltd.

FUREN Group Pharmaceutical Co., Ltd.

600781
Rank in Stocks #23723
FUREN Group Pharmaceutical Co., Ltd. primarily focuses on the development and... FUREN Group Pharmaceutical Co., Ltd. primarily focuses on the development and distribution of medicinal products across China, with key operations located in Henan Province and Shanghai. The company offers a wide array of traditional Chinese medicines, available in various formats such as capsules, tablets, granular formulations, gels, injectable solutions, and oral liquids. Among its notable therapeutic solutions are granular preparations designed for cardiac ailments, alongside encapsulated treatments for managing diabetes and high cholesterol. Furthermore, the company diversifies its business by engaging in warehousing logistics and commercial trading activities. Established in 1996, the firm maintains its headquarters in Shanghai, China.
Share Price
$0.11158369
Last synced: 2023-06-19
Market Cap
$69.98M
Change (1 day)
1.95%
Change (1 year)
0.00%
Country
CN
Trade FUREN Group Pharmaceutical Co., Ltd. (600781)

Category

Healthcare
Revenue for FUREN Group Pharmaceutical Co., Ltd. (600781)
Revenue in Aug 2026 TTM: 0
According to FUREN Group Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for FUREN Group Pharmaceutical Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN